ArticleAmerican journal of hematology2026
Risk-Adjusted Comparison of Survival in Chronic Myelomonocytic Leukemia With and Without Allogeneic Stem Cell Transplant: Mayo Clinic Experience in 775 Consecutive Patients.
Ali Alsugair et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.